News | August 12, 2022
The facility is designed with advanced analytical equipment to provide testing services such as In-vitro Permeation testing
The GMP facility is equipped with state of art machinery for the needs of Global commercial requirements
The powder is approved for the treatment of adjunct therapy in moderate to severe Covid-19 patients
2DG has been given emergency approval by the Drug Controller General of India for COVID-19 patients in the country
The commercial production in the SML was started in November 1989.
Subscribe To Our Newsletter & Stay Updated
